Physician profile
Amanda Thompson
NPI 1043604044
$922.00
in general payments reported to CMS, 2019-2025
13 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.98 · 2020: $90.58 · 2021: $466 · 2022: $68.69 · 2023: $88.52 · 2024: $48.42 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $322.51 | 2020-2022 | |
| Celgene Corporation | $125.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.95 | 2021 | |
| Merck Sharp & Dohme LLC | $80.67 | 2019-2025 | Gardasil 9, Enflonsia, Vaxneuvance |
| Sanofi Pasteur INC. | $73.35 | 2022-2024 | |
| Pfizer INC. | $48.26 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $42.81 | 2022-2023 | |
| Cranial Technologies, INC | $33.18 | 2023-2025 | Doc Band |
| Ars Pharmaceuticals Operations, INC. | $32.73 | 2025 | Neffy |
| Ipsen Biopharmaceuticals, INC | $17.91 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $17.03 | 2020 | |
| Neurelis, INC. | $15.11 | 2025 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $13.49 | 2023 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.